Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
about
Modern extraction techniques and their impact on the pharmacological profile of Serenoa repens extracts for the treatment of lower urinary tract symptomsRecruitment of participants to a clinical trial of botanical therapy for benign prostatic hyperplasia.Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia.Phytotherapy for Benign Prostatic Hyperplasia.Management of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia by general practitioners in JakartaOutcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.Current benign prostatic hyperplasia treatment: impact on sexual function and management of related sexual adverse events.Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK.Pelvic ultrasound evaluation for benign prostatic hyperplasia: prediction of obstruction.Inflammatory mediators in the development and progression of benign prostatic hyperplasia.Can benign prostatic hyperplasia be identified in the primary care setting using only simple tests? Results of the Diagnosis IMprovement in PrimAry Care Trial.Occurrence of overactive bladder in patients with benign prostatic hyperplasia in the Czech Republic.Development of a quality of life scale specific for patients with benign prostatic hyperplasia.Real-world use of Permixon® in benign prostatic hyperplasia--determining appropriate monotherapy and combination treatment.Tailoring pharmacotherapy for male lower urinary tract symptoms: A prospective, multicenter, observational trial.A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH).Studies on Chromatographic Fingerprint and Fingerprinting Profile-Efficacy Relationship of Saxifraga stolonifera Meerb.Practice Patterns in Diagnosis and Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia among General Practitioners: Lessons Learnt from a Greek SurveyPatient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review.
P2860
Q21256691-C859AED3-FCD8-479E-8154-7D969666B80EQ30427093-37AFCC3A-75D7-4D83-B743-0105B5F9754EQ30432603-469EA1A3-5AC6-41B1-B601-528B4DCCA320Q34526601-5D3F386E-900B-48BC-82A2-0065707AEFA4Q35207995-5920ED16-5CEC-45EB-91BB-74AAF41B06EBQ35989759-2C853FE3-C2A1-4226-A543-3EE558A544E7Q37896170-F8D763BF-677B-495E-88D8-CEB3BC405650Q38198262-77ED242D-3594-449C-A0A4-3D9CAB5AEC11Q38198534-8FC32B78-B313-4A39-A33A-7FF8B100F9B3Q38968019-97F32876-4F28-47CF-B029-B98C86960561Q39990115-553462C5-B510-4D7A-8085-D2F0E3CABA46Q44125663-9FBBA691-51E2-4966-B342-65B5EE5F0062Q44760919-0800455B-A81C-4AC6-9CFC-246F8DAF9828Q47694772-DFFD3B68-A64E-4494-8B6C-7AE666532009Q48139585-B5F295BD-D609-4DC6-99D4-583AA8171A6EQ48167470-9EF67154-9821-421B-B887-50DCFA689E59Q51592487-F05227E5-EE30-45B7-894D-FC1A349043E3Q55240011-0AC907C6-3558-45FF-BD8C-4A2B5AF881E3Q55437967-303F13BD-1507-40A0-B34B-F80A616E8218
P2860
Profile and management of patients treated for the first time for lower urinary tract symptoms/benign prostatic hyperplasia in four European countries.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Profile and management of pati ...... ia in four European countries.
@en
Profile and management of pati ...... ia in four European countries.
@nl
type
label
Profile and management of pati ...... ia in four European countries.
@en
Profile and management of pati ...... ia in four European countries.
@nl
prefLabel
Profile and management of pati ...... ia in four European countries.
@en
Profile and management of pati ...... ia in four European countries.
@nl
P2093
P2860
P1433
P1476
Profile and management of pati ...... ia in four European countries.
@en
P2093
BPH USAGE Study Group
Charles Taïeb
Nathalie Théret
Richard-Olivier Fourcade
P2860
P304
P356
10.1111/J.1464-410X.2008.07498.X
P577
2008-02-15T00:00:00Z